All Opportunities
HRSA
HRSA-26-052
discretionary
Forecasted

​Sickle Cell Disease Regional Care Excellence (SoRCE) Program

Health Resources and Services AdministrationCloses May 31, 2026Posted December 11, 2025

Official Federal Notice

View the complete notice on Grants.gov

View on Grants.gov

Summary

Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to...
Read full notice on Grants.gov

Eligible Applicants

  • Other
  • Private institutions of higher education
  • Public institutions of higher education

Additional Eligibility Details

Hospitals or clinicsHealth centers.Documentation must be provided to demonstrate that your organization has at least five years of experience in working with individuals who have sickle cell disease (SCD).​

Assistance Listings

93.365
Sickle Cell Treatment Demonstration Program

Funding Instrument

Cooperative Agreement

CFDA / Assistance Listing Numbers

93.365

Topics

Program Contact

Information on this page is sourced from official federal notices on Grants.gov. Always verify eligibility, deadlines, and requirements using the official notice. Funding Radar is not affiliated with the U.S. government.

Key Details

Award Ceiling

$950,000

Total Program Funding

$6,650,000

Expected Awards

7

Posted

December 11, 2025

Deadline

May 31, 2026

68 days remaining

Cost Sharing

Not Required

Agency

HRSA

View Official Notice

Data from Grants.gov

Last fetched: 3/23/2026